Background: The upper limit of the natural decline in creatinine clearance is 1 ml/min/year. To define the loss of renal function, we started a long-term assessment of patients with ovarian cancer treated by whole abdominal irradiation (WAI) with preceding cisplatin chemotherapy (CDDP) and secondlook laparotomy (SLL).
Introduction
Adverse effects of irradiation on kidneys were first discussed by Baerman et al. in 1904 [1] . In 1952 and 1964, Kunkler and Luxton described clinical syndromes of radiation nephropathy by the analysis of patients treated for seminoma [2, 3] . Many patient reports of renal disorders after irradiation subsequently followed in rapid sequence [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Hallmarks of chronic radiation nephropathy are arterial hypertension, glomerular sclerosis/hyalinization, fibrinoid changes in arterioles and interlobular arteries, tubular atrophy and interstitial fibrosis [19] .
A task force under the direction of the National Cancer Institute defined tolerance doses of various organs and tissues to therapeutic irradiation and published their recommendations in 1991 [20] . To support these recommendations, further systematic clinical studies are warranted. Cassady stressed in a recent article the need for well designed studies with long follow-up periods to accurately assess late radiation toxicity [21] .
In this context, we examined the radiation nephropathy of our patients with advanced and non-advanced ovarian cancer who were treated in controlled protocols by surgery followed by either CDDP, second-look laparotomy and WAI or WAI exclusively following surgery. The long-term assessment examined especially the impact and mutual influence of the two potentially nephrotoxic agents, CDDP and irradiation, sequentially given, on renal function. 
Abbreviations: CDDP -cis-diamminedichloride platinum; WAI -whole abdominal irradiation; CC1 -creatinine clearence. values followed by " were calculated according to Cockcroft et al. [22] or Jeliffe et al. [23] ; OF -open field; MS -moving strip: DM -diabetes mellitus, Hhypertension (H° = in addition to hypertension, history of excessive consumption of phenacetin).
to undergo investigaton of renal-tubular function in addition to assessment of glomerular filtration rate. These 20 patients constituted the investigated group, while the remaining 36 patients formed the noninvestigated group. In the investigated group, 11 of 20 patients (FIGO stage: 2 x IC. 1 x IIB, 2 x IIC, 6 x HI) had received CDDP chemotherapy, 10 patients four to six cycles with 80/m 2 /cycle and 1 patient nine cycles. In addition to CDDP as the only nephrotoxic agent, combination chemotherapy contained either melphalan, melphalan and hexamethylmelamin, or cyclophosphamide. The FIGO stage of the nine investigated patients without CDDP chemotherapy were 5 x IB/C, 2 x MB, and 2 x III. In the non-investigated group 14 of 36 patients received CDDP chemotherapy (FIGO stage: 3 x IC. 5 x 2B/C. and 6 x III). The FIGO stage of the 22 patients in the non-investigated group who did not receive CDDP chemotherapy were 21 x IB/C, and 1 x III.
For the investigation of a possible adverse effect of cisplatin on renal function, we pooled patient data from the investigated (n = 20) and non-investigated (;; = 36) patients and classified these individuals into two new groups, WAI patients treated with cisplatin (/; = 25) and those receiving no cisplatin chemotherapy (;J = 31). Median age and follow-up periods for the former group were 52 years (28-72) and 83 months . respectively, and for the latter group 53 years and 102 months . respectively.
Kidney irradiation dose
To deliver whole abdominal irradiation (WAI), the moving strip and. later, the open field techniques were used. Patients were treated in prone position using anterior-posterior fields for a target volume extending from the domes of the diaphragms to the lower border of the obturator foramina: 5 H.V.L. lead shielding were inserted to shield the kidneys from the posterior field. The median age of the investigated group at diagnosis was 52 years . All 20 patients were tumor-free at the time of the study. The median follow-up period of these patients was 117 months (61-156). Additional clinical data and details of radiation and chemotherapy are given in Table 1 . Analyses of all 20 patients included clinical history, physical examination, blood and urine tests and kidney ultrasound. At the end of the observation period, 24-hour urine specimens were collected from all patients in order to determine creatinine clearance, proteinuria. and tubular function by excretion of uric acid, phosphate and glucose. Urine analysis including measurement of pH for assessment of tubular acidification was performed in random morning urine samples. Prior to any therapy such as WAI or chemotherapy, creatinine clearance was measured from 24-hour urine specimens in eight patients. For the remaining 12 patients, the creatinine clearance was calculated using the formulas reported by Cockcroft et al. [22] and Jelliffe et al. [23] . To predict creatinine clearance, the former relies on serum creatinine. body weight and age. and the latter on serum creatinine and age only. In our analyses, we used the first formula, except in a few patients with significant obesity (body mass index >30 kg/m 2 ), in whom we applied the second formula because of overestimation of creatinine clearance by inclusion of excessive body weight into the calculations.
Study group: Non-investigated patients (n = 36)
The median age of the non-investigated group at diagnosis was 57 years . Twenty-three of the 36 patients were tumor-free at the time of the renal function investigations. The median follow-up period Figure 1 Creatinine clearance as a function of time in 25 patients treated with CDDP and WAI. The dashed line indicates the natural age-related decline of the creatinine clearance (1 ml/year) according to Bjornsson [24] . A total of 76% of the patients had a decline greater than 1 ml/year, and 64% of more than 2 ml/year. [24] . A total of 71% of the patients demonstrated a decline greater than 1 ml/year, and 55% of more than 2 ml/year. of these patients was 81 months Creatinine clearance values were calculated in all of these patients, as stated above.
Kidney function
Kidney function in all 56 patients of both the investigated and the non-investigated groups was analyzed as a function of time. In addition, the evolution of the glomerular filtration rate in these patients was compared to the age-related, natural decline in creatinine clearance [22] [23] [24] [25] [26] [27] Importantly, according to Bjornsson et al [24] , creatinine clearance in adults, such as our study patients, decreases by approximately 1 ml/min/year independent of gender. This value was used as reference for the analyses of our patients.
Results

General evolution of glomerular filtration rate
The main purpose of this study was to investigate the glomerular filtration rate as a function of time after WAI. In our 56 patients the decline in creatinine clearance was more pronounced than in healthy subjects during an identical observation period. The mean creatinine clearance in our patients decreased by 18 ml/min (from 84 ± 16 to 66 ± 21 ml/min; P < 0.05) during the median and mean observation period of eight years.
Effect of CDDP and WAI versus WAI alone on glomerular filtration rate
During the study period, the decline in mean creatinine clearance of patients exposed to CDDP and irradiation (n = 25) was 19 ml/min, very close to the 16 ml/min in patients treated by radiotherapy alone (n = 31), when a comparable observation time was considered. Additionally, the results of the creatinine clearances of these two patient groups were plotted against time (Figures 1 and  2) . As shown in Figure 1 , 19 of 25 (76%) of the patients in the group treated with chemotherapy and irradiation had declines in creatinine clearance greater than 1 ml/year (with 1 ml/year as the natural decline in renal function of a normal adult population of comparable age; 24). Moreover, 16 of 25 (64%) of these patients had losses of more than 2 ml/year. In the group with irradiation alone, the numbers were 71% and 55%, respectively ( Figure 2) .
Effect of CDDP and WAI on kidney function of the investigated patient group
Kidney function in the 20 patients in the investigated group was analyzed in greater detail with respect to glomerular filtration rate, kidney size, and renal tubular function. Relevant data of patients, treatment methods and laboratory results are summarized in Tables 1 and 2 .
Glomerular filtration rate. Altogether, during the followup period of 117 months (61-156), the mean creatinine clearance significantly decreased from 86 ± 13 ml/min to 58 ± 15 ml/min (P < 0.05), with a mean value for the patients with CDDP and WAI of 62± 16 ml/min and for the patients with WAI alone 54 ±11 ml/min. At the end of the observation period, 11 of the 20 patients demonstrated creatinine clearances below 60 ml/min; in 9 of these 11 patients, creatinine clearance was 40-59 ml/min, and in the remaining two, 39 and 29 ml/min.
In these 20 patients, we were not able to correlate renal radiation dose and decline in kidney function on the basis of the data reported in Table 1 .
Tubular function.
Renal tubular function of the 20 investigated-group patients was analyzed in detail. The results are summarized in Table 2 .
Tubular reabsorption of phosphate (TRP) measured in individuals with normal renal function (creatinine clearance) was previously reported by Popovtzer et al. to be All biochemical results were obtained at the end of the observation period. a Patients 1-11 received WAI and additional chemotherapy as depicted in Table 1 FE ur (%): Fractional excretion of uric acid = "™^d£ZL x 100. TRP:
Tubular reabsorption of phosphate = I -fractional excretion of phosphate.
in the order of 85% [28] . In our 20 patients, TRP was 77% ± 6% in the 11 cases treated with CDDP and WAI and 72% ± 6% in the 9 individuals treated with radiotherapy alone. Considering reduced mean creatinine clearances of 62 ± 16 ml/min in the former and of 54 ± 11 ml/min in the latter group, the small reduction in TRP due to the increase in fractional excretion of phosphate is an expected finding according to Popovtzer et al. [28] . Thus, the small reduction in TRP due to increased fractional phosphate excretion merely reflects the reduction in renal function and may in addition be interpreted as a consequence of mild secondary hyperparathyroidism.
The fractional excretion ofuric acid (FE ur ) was 12.5% ± 4.1% in patients treated with CDDPand 12.2% ± 3.5% in patients not exposed to chemotherapy. These results are not significantly different from the normal excretion of uric acid, which is generally on the order of 6% to 12% of the filtered load [29] and 12.0% ± 2.9% in nonpregnant women [30] . However, as renal function deteriorates, there is a progressive increase in excretion and a relative clearance of uric acid because of increased tubular secretion of urate and incomplete reabsorption of filtered urate [31] . According to a plot of glomerular filtration rate versus FE ur by Calabrese et al. [32] , both mean values of FE ur obtained in our patient subgroups are only slightly above the expected value of about 11%: however, in that publication 10% was considered to be the upper limit of a normal FE ur in unimpaired kidney function.
Except in the two patients with known diabetes mellitus, no glucosuria due to tubular damage was found. Only one patient showed a slight proteinuria of 0.25 g/day, which may well be explained by hypertension and past abuse of phenacetin. In 18 of the 20 patients, a pH of 5.0 was measured in random urine samples. Although this finding does not entirely exclude an acidification defect [33] , a significant distal renal tubular disorder with respect to acid excretion seems unlikely.
Finally, potassium and magnesium measured in serum were in the normal range except in one patient with a potassium of only 3.0 mmol/1 (3.5-4.7 mmol/1) and in three patients with borderline to mild hypomagnesemia of 0.54-0.68 mmol/1 (0.70-0.95 mmol/I). These findings satisfactorily excluded tubulopathy with loss of electrolytes, typically found in cisplatin-induced nephropathy.
Kidney size. The kidney length found in normal adult females is slightly less than 11 cm [34] . However, renal length decreases by 2 cm between the ages of 50 and 80 years [35] . Therefore, as measured by ultrasound in the investigated group, renal size was practically not affected, with a mean of 10.0 ± 1.1 cm in the CDDP-treated group and of 10.3 ± 1. 1 cm in the group with radiotherapy alone. Most likely, the only minimal reduction of kidney size reflected the glomerular function slightly reduced over many years and present at the observation time. Even in the two patients with the lowest creatinine clearances of 29 ml/min and 37 ml/min, kidney length was still close to 9 cm. These findings confute pre-existing chronic renal failure. In addition, renal ultrasound examination revealed no further pathological findings such as increased echogenicity, cortical atrophy or parenchymal cysts in any of the 20 patients.
Comorbidity. Co-morbid conditions were found in eight of the patients in this group which could potentially have an adverse effect on kidney function, as shown in Table 2 .
Arterial hypertension was treated in six patients, including the one with excessive consumption of phenacetin, for durations of five months to six years. However, the mean creatinine clearances of hypertensive and normotensive patients were almost identical: 54 ml/min and 60 ml/min, respectively. Two patients suffered from diabetes mellitus. Only one patient with hypertension, who also had the worst renal function of the 20 patients analyzed, showed borderline proteinuria of 0.25 g/24 h (patient 2, Table 1 ). In addition, this patient was the only one who demonstrated significant abnormality in urinalysis, namely microhematuria.
Discussion
Radiation nephritis is a well-known entity which is, however, difficult to analyze quantitatively because of many confounding variables. The key findings of 13 previously published studies or case reports are summarized in Table 3 . The observed effects of irradiation on renal function are heterogeneous, depending on total renal dose, irradiated renal volume, on uni-or bilateral kidney irradiation, and on length of patient follow-up periods. The duration of the present study is extensive and the patient numbers high, comparable to only four other studies (Table 3) [3, 9, 17, 36] .
Chemotherapy is a common variable in the assessment of radiation nephritis, and chronic renal failure is a rare but well-described complication of cisplatin [37] [38] [39] . Remarkably, there is no published report separately analyzing the effects of chemotherapy on the course of radiation nephropathy, so our study is thus unique with respect to its direct comparison of irradiated patients treated with and without cisplatin. However, we found no differences with respect to cisplatin. Experimental studies analyzing mice or rats clearly demonstrated an enhancing effect of cisplatin on kidney damage caused by irradiation [40] [41] [42] [43] . In addition, second-look laparotomy had no negative effect on renal function in the patients who received chemotherapy.
Other important confounding factors are hypertension and diabetes mellitus. As in most other studies, the precise adverse effects of these two underlying diseases on kidney function in our subjects is difficult to judge, since the durations and treatments of hypertension and diabetes mellitus are not known. Tn addition, high blood pressure in our patients may be a result of radiation nephropathy but could also represent essential hypertension, especially in the presence of well-preserved kidney function, such as in the study patients 10 and 11 (Table 1) . However, there were no cases of malignant hypertension and in our investigated-patient group kidney function did not differ in hypertensive and normotensive individuals.
The decline of renal function in our population was pronounced despite the low single doses of 0.65 and 1.15 Gy. The decrease of the mean glomerular filtration rate in our 56 patients was more than twice the expected natural age-related decline of 1 ml/min/year [24] .
In addition to creatinine clearance, we analyzed several factors reflecting renal tubular functions. Despite the reduction of glomerular filtration rate, renal tubular function was well preserved. Therefore, most of the lateeffect damage of low-dose irradiation to the kidney may have occurred to endothelial cells present in arterioles and in glomerular capillaries rather than to tubular cells due to interstitial inflammation [13] .
In summary, we found no patients with chronic radiation nephropathy in our series of 56 patients who received WAI or CDDP and SLL followed by WAI after epithelial ovarian cancer surgery. Nevertheless, analyses of kidney function over time showed a more pronounced decline of creatinine clearance in our patients than in the normal population. Interestingly, the addition of cisplatin and SLL did not adversely influence the decrease in renal function.
